CH ELM (R4)
1.9.1 - release
This page is part of the Observations of notifiable communicable infectious diseases (v1.9.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Active as of 2025-03-26 |
{
"resourceType" : "ValueSet",
"id" : "ch-elm-results-component-antibiotic-tb",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet ch-elm-results-component-antibiotic-tb</b></p><a name=\"ch-elm-results-component-antibiotic-tb\"> </a><a name=\"hcch-elm-results-component-antibiotic-tb\"> </a><a name=\"ch-elm-results-component-antibiotic-tb-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"http://loinc.org\"><code>http://loinc.org</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"https://loinc.org/18934-0/\">18934-0</a></td><td>Isoniazid [Susceptibility]</td></tr><tr><td><a href=\"https://loinc.org/18921-7/\">18921-7</a></td><td>Ethambutol [Susceptibility]</td></tr><tr><td><a href=\"https://loinc.org/18974-6/\">18974-6</a></td><td>rifAMPin [Susceptibility]</td></tr><tr><td><a href=\"https://loinc.org/18973-8/\">18973-8</a></td><td>Pyrazinamide [Susceptibility]</td></tr></table></li></ul></div>"
},
"url" : "http://fhir.ch/ig/ch-elm/ValueSet/ch-elm-results-component-antibiotic-tb",
"version" : "1.9.1",
"name" : "ChElmResultsComponentAntibioticTb",
"title" : "CH ELM Results Antibiotic Tb",
"status" : "active",
"experimental" : false,
"date" : "2025-03-26T08:01:17+00:00",
"publisher" : "Federal Office of Public Health FOPH",
"contact" : [
{
"name" : "Federal Office of Public Health FOPH",
"telecom" : [
{
"system" : "url",
"value" : "https://www.bag.admin.ch/bag/en/home/das-bag/kontakt-standort.html"
}
]
}
],
"description" : "The \"ch elm results antibiotic tb\" group provides a curated set of codes representing specific antibiotics. Each code within this group is selected to ensure consistency and accuracy for medical coding related to the primary LOINC codes. Clients using the \"ch elm results antibiotic tb\" group should refer to the provided codes to ensure they capture and report antibiotic information correctly and consistently",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "CH"
}
]
}
],
"copyright" : "CC0-1.0",
"compose" : {
"include" : [
{
"system" : "http://loinc.org",
"concept" : [
{
"code" : "18934-0",
"display" : "Isoniazid [Susceptibility]"
},
{
"code" : "18921-7",
"display" : "Ethambutol [Susceptibility]"
},
{
"code" : "18974-6",
"display" : "rifAMPin [Susceptibility]"
},
{
"code" : "18973-8",
"display" : "Pyrazinamide [Susceptibility]"
}
]
}
]
}
}